This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
5 MedTech Stocks That Have Outperformed the Industry in 2020
by Debanjana Dey
Here are a few MedTech stocks which continued to outperform their respective industries amid the pandemic and can turn out to be wise investment choices.
Top Ranked Growth Stocks to Buy for December 17th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 17th
Medtronic (MDT) Releases Positive Study Results of RFA Therapy
by Zacks Equity Research
Medtronic's (MDT) OsteoCool RFA System is expected to provide better relief from debilitating pain for cancer patients.
Here's Why You Should Add Hologic (HOLX) to Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about Hologic (HOLX) on robust growth of the Diagnostics segment and regulatory approvals.
Here's Why Hologic (HOLX) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does Hologic (HOLX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks.com featured highlights include: D.R. Horton, Crocs, Hologic and Louisiana-Pacific
by Zacks Equity Research
Zacks.com featured highlights include: D.R. Horton, Crocs, Hologic and Louisiana-Pacific
Zimmer Biomet (ZBH) Shows Strong Recovery Amid COVID-19 Woes
by Zacks Equity Research
Owing to lack of clarity around the scope and duration of the coronavirus pandemic, Zimmer Biomet (ZBH) is unable to gauge the impact on its overall business in 2020.
Abbott (ABT) Gains CE Mark for Quantitative Serology Testing
by Zacks Equity Research
The test is set to be used on Abbott's (ABT) ARCHITECT and Alinity i platforms.
Eloxx Pharmaceuticals (ELOX) in Focus: Stock Moves 6.9% Higher
by Zacks Equity Research
Eloxx Pharmaceuticals (ELOX) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
3 Reasons Why Growth Investors Shouldn't Overlook Hologic (HOLX)
by Zacks Equity Research
Hologic (HOLX) could produce exceptional returns because of its solid growth attributes.
Here's Why You Should Hold on to Tandem Diabetes (TNDM) Stock
by Zacks Equity Research
Investors continue to be optimistic about Tandem Diabetes (TNDM) on robust pump sales and shipments.
Abbott (ABT) Launches Immunity Boosting Hydration Solution
by Zacks Equity Research
Abbott's (ABT) latest hydration solution with specifically chosen nutrients along with optimal balance of electrolytes and glucose is expected to boost immunity.
Explore These 4 Momentum Stocks Using Driehaus Strategy
by Nitish Marwah
Investors who have the propensity to take higher risks can think of investing in momentum stocks to boost their gains.
NEOGEN (NEOG) Launches DNA Screening Tool for Canine Care
by Zacks Equity Research
NEOGEN's (NEOG) latest DNA screening tool is expected to aid veterinarians to provide healthy lifestyle recommendations for a longer and happier life for each pet and its family.
Two Big Monetary Meetings: Global Week Ahead
by John Blank
The Bank of England (BoE) is not expected to alter its asset purchase target or its 0.1% Bank Rate. But obviously, the state of Brexit negotiations and the outcome into the New Year, and how markets take it, may be impactful to its assessments.
The Zacks Analyst Blog Highlights: Wayfair, Qorvo, Williams-Sonoma, Deere & Co and Hologic
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Wayfair, Qorvo, Williams-Sonoma, Deere & Co and Hologic
The Zacks Analyst Blog Highlights: Addus HomeCare, Fulgent Genetics and Hologic
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Addus HomeCare, Fulgent Genetics and Hologic
Zimmer Biomet (ZBH), HSS Partner to Advance Remote Patient Care
by Zacks Equity Research
Zimmer Biomet's (ZBH) mymobility with Apple Watch platform aids in transforming virtual patient care via the latest partnership with HSS.
Top Ranked Growth Stocks to Buy for December 11th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 11th
5 Breakthrough Stocks Doubling S&P 500 Gains in 2020
by Urmimala Biswas
W, QRVO, WSM, DE, HOLX more than double the S&P 500's corresponding return in 2020.
LabCorp's (LH) Pixel Kit Gets EUA for Over-the-Counter Use
by Zacks Equity Research
This approval is expected to increase access to LabCorp's (LH) COVID-19 testing, thereby broadening its customer base.
3 MedTech Growth Stocks With Solid Prospects for 2021
by Zacks Equity Research
Here are a few MedTech growth stocks poised for a rebound that investors can scoop up to reap profits going into 2021.
Medtronic (MDT) Carpediem to Tap Pediatric Kidney Care Market
by Zacks Equity Research
Medtronic's (MDT) Carpediem CRRT system compares favorably with the traditional three times a week therapy session.
Bruker (BRKR) Hits New 52-Week High: What's Driving It?
by Zacks Equity Research
Bruker (BRKR) is optimistic about maintaining a robust product portfolio along with its continued COVID-19-led progress.
S&P 500 Momentum to Continue on Stimulus Hopes: 4 Picks
by Aniruddha Ganguly
Here we pick four S&P 500 stocks -- LB, HOLX, MU & TGT -- that have strong growth prospects driven by the rising stimulus hopes and vaccine approvals.